Literature DB >> 4026271

Comparative in vitro activities of selected antimicrobial agents against Edwardsiella tarda.

J F Reinhardt, S Fowlston, J Jones, W L George.   

Abstract

MICs of 14 antimicrobial agents for 29 strains of Edwardsiella tarda were determined by an agar dilution method. Of the agents tested, ciprofloxacin, enoxacin, and norfloxacin were the most active on a weight basis. All strains were also susceptible to clinically achievable concentrations of ampicillin, chloramphenicol, tetracycline, trimethoprim, sulfamethoxazole, trimethoprim plus sulfamethoxazole, cefotaxime, and gentamicin. Ninety percent of the strains demonstrated high-level resistance to polymyxin B and colistin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026271      PMCID: PMC180198          DOI: 10.1128/AAC.27.6.966

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria.

Authors:  K Montgomery; L Raymundo; W L Drew
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

2.  Human infection with Edwardsiella tarda.

Authors:  G W Jordan; W K Hadley
Journal:  Ann Intern Med       Date:  1969-02       Impact factor: 25.391

3.  Edwardsiella tarda--identification and clinical significance. Report of two cases.

Authors:  H B Chatty; T L Gavan
Journal:  Cleve Clin Q       Date:  1968-10

4.  Invasive enterocolitis caused by Edwardsiella tarda.

Authors:  P K Marsh; S L Gorbach
Journal:  Gastroenterology       Date:  1982-02       Impact factor: 22.682

5.  Edwardsiella tarda gastroenteritis associated with a pet turtle.

Authors:  P Nagel; A Serritella; T J Layden
Journal:  Gastroenterology       Date:  1982-06       Impact factor: 22.682

6.  Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

Authors:  J F Reinhardt; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.

Authors:  L J Goodman; R M Fliegelman; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.

Authors:  J R Carlson; S A Thornton; H L DuPont; A H West; J J Mathewson
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Extraintestinal human infection caused by Edwardsiella tarda.

Authors:  J E Clarridge; D M Musher; V Fainstein; R J Wallace
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

10.  Natural colistin resistance in Edwardsiella tarda.

Authors:  T Muyembe; J Vandepitte; J Desmyter
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

View more
  4 in total

Review 1.  [Enoxacin: spectrum and activity of its antibacterial effect].

Authors:  A Bauernfeind; H Flamm; H Grimm; H Hahn; F Kayser; W Opferkuch; J Potel; R Malottke; H G Sonntag; W H Traub
Journal:  Infection       Date:  1986       Impact factor: 3.553

2.  Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae.

Authors:  I Stock; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Mechanisms of intrinsic resistance to antimicrobial peptides of Edwardsiella ictaluri and its influence on fish gut inflammation and virulence.

Authors:  Javier Santander; Taylor Martin; Amanda Loh; Camilo Pohlenz; Delbert M Gatlin; Roy Curtiss
Journal:  Microbiology (Reading)       Date:  2013-05-15       Impact factor: 2.777

Review 4.  Mycotic aneurysm caused by Edwardsiella tarda successfully treated with stenting and suppressive antibiotic therapy: a case report and systematic review.

Authors:  Kei Furui Ebisawa; Sho Nishimura; Shungo Yamamoto; Goh Ohji; Kentaro Iwata
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-05-10       Impact factor: 3.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.